Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Ondansetron on Myocardial Repolarization in Children Receiving Chemotherapy

NCT01896440 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT01896440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01896440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Ondansetron on Myocardial Repolarization in Children Receiving Chemotherapy
Lead sponsor
University of Oklahoma
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2013
Completion date
October 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant childhood neoplasm